Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ABBVIE INC
- Publication Date
- 2020-09-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] related application
[0002] This application claims priority to provisional application 62 / 547,402 filed August 18, 2017, provisional application 62 / 660,102 filed April 19, 2018, and non-provisional application PCT / US2018 / 043321 filed July 23, 2018 , all applications are hereby incorporated by reference in their entirety for all purposes.
[0003] joint research agreement
[0004] The subject matter disclosed in this application was made by or on behalf of AbbVie Inc. and / or Neurocrine Biosciences, Inc., which were parties to a joint research agreement in effect on or before the effective filing date of this application, and such subject matter was made in Results of activities carried out within the scope of a joint research agreement. technical field
[0005] The present invention relates to a pharmaceutical composition of Compound A and a pharmaceutically acceptable salt, and methods of using such compositions. Background technique
[0006] Endometriosis is ...